Person

Anthony Welters

Director, Gilead Sciences

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$3.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 26, 2026GILDSale4,600$148.82$685K
Aug 26, 2026GILDSale6,880$148.82$1.0M
Aug 26, 2026GILDSale3,402$148.24$504K
Aug 26, 2026GILDSale3,118$148.31$462K
Mar 3, 2025LSale1,197$86.87$104K
Dec 2, 2024LSale1,146$86.81$99K
Sep 3, 2024LSale1,088$81.41$89K
Jun 3, 2024LSale963$75.80$73K
Mar 1, 2024LSale951$75.01$71K
Dec 1, 2023LSale715$70.16$50K

SEC reporting-owner ID (CIK) 1213307 · all filings on EDGAR